- All sections
- C - Chemistry; metallurgy
- C07D - Heterocyclic compounds
- C07D 207/16 - Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
Patent holdings for IPC class C07D 207/16
Total number of patents in this class: 1154
10-year publication summary
|
89
|
98
|
84
|
106
|
112
|
102
|
68
|
67
|
56
|
0
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| F. Hoffmann-La Roche AG | 7939 |
30 |
| Novartis AG | 11289 |
18 |
| Bristol-myers Squibb Company | 4883 |
17 |
| Givaudan SA | 1820 |
16 |
| Epics Therapeutics | 18 |
14 |
| Hoffmann-La Roche Inc. | 3255 |
13 |
| Life Technologies Corporation | 3194 |
12 |
| President and Fellows of Harvard College | 5905 |
12 |
| Biogen MA Inc. | 912 |
11 |
| Aichi Steel Corporation | 371 |
10 |
| Cytokinetics, Inc. | 270 |
10 |
| Omeros Corporation | 297 |
9 |
| Tokushima University | 201 |
9 |
| Xwpharma Ltd. | 59 |
9 |
| Amgen Inc. | 3897 |
8 |
| Abbvie Inc. | 1779 |
8 |
| Enanta Pharmaceuticals, Inc. | 421 |
8 |
| The Regents of the University of California | 19493 |
7 |
| Massachusetts Institute of Technology | 9909 |
7 |
| Siemens Medical Solutions USA, Inc. | 1544 |
7 |
| Other owners | 919 |